A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.
about
Hematopoietic and mesenchymal stem cells for the treatment of chronic respiratory diseases: role of plasticity and heterogeneityMesenchymal stem cells: environmentally responsive therapeutics for regenerative medicineRegeneration of the lung: Lung stem cells and the development of lung mimicking devicesEndogenous and Exogenous Stem/Progenitor Cells in the Lung and Their Role in the Pathogenesis and Treatment of Pediatric Lung DiseaseLung Regeneration: Endogenous and Exogenous Stem Cell Mediated Therapeutic ApproachesNano-Therapeutics for the Lung: State-of-the-Art and Future PerspectivesStem Cells and Their Mediators - Next Generation Therapy for Bronchopulmonary DysplasiaCell-based therapy in lung regenerative medicineMesenchymal stem cells as a vector for the inflammatory prostate microenvironmentA review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methodsOptimization of pre-transplantation conditions to enhance the efficacy of mesenchymal stem cellsHuman Tubal-Derived Mesenchymal Stromal Cells Associated with Low Level Laser Therapy Significantly Reduces Cigarette Smoke-Induced COPD in C57BL/6 miceGenetically modified mesenchymal stromal cells in cancer therapyHuman mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trialsFrom Here to There, Progenitor Cells and Stem Cells Are Everywhere in Lung Vascular RemodelingMesenchymal stem cells in the treatment of chronic lung diseaseFunctional characterisation of bone marrow-derived mesenchymal stromal cells from COPD patientsThe impracticality of biomedical rejuvenation therapies: translational and pharmacological barriersStrategies for whole lung tissue engineering.A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis.A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema.Combined Bone Marrow-Derived Mesenchymal Stromal Cell Therapy and One-Way Endobronchial Valve Placement in Patients with Pulmonary Emphysema: A Phase I Clinical Trial.Clinical observation of umbilical cord mesenchymal stem cell treatment of severe idiopathic pulmonary fibrosis: A case report.Serious adverse events of cell therapy for respiratory diseases: a systematic review and meta-analysisAn official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases.Stem cells and cell therapies in lung biology and diseases: conference report.Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesotheliomaAutologous Stromal Vascular Fraction in the Intravenous Treatment of End-Stage Chronic Obstructive Pulmonary Disease: A Phase I Trial of Safety and Tolerability.Human mesenchymal stem cells modulate inflammatory cytokines after spinal cord injury in rat.Stem cell bioprocess engineering towards cGMP production and clinical applicationsMSC therapy attenuates obliterative bronchiolitis after murine bone marrow transplantEffects of different mesenchymal stromal cell sources and delivery routes in experimental emphysemaTherapeutic effects of amniotic fluid-derived mesenchymal stromal cells on lung injury in rats with emphysema.Primary mesenchymal stem cells in human transplanted lungs are CD90/CD105 perivascularly located tissue-resident cells.The clinical use of regenerative therapy in COPDLung Regeneration Therapy for Chronic Obstructive Pulmonary Disease.Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathwaysLung extracellular matrix and fibroblast function.Pilot safety study of intrabronchial instillation of bone marrow-derived mononuclear cells in patients with silicosis
P2860
Q21284513-215546C8-723C-4831-AE61-6BB2A40B41A4Q24632756-3FB85840-DC2C-4780-A7A6-E55240B14222Q26750856-571C40B6-C9C7-42B9-A6EB-0C215D4F8FDEQ26752355-5C13ADDD-17A6-4E10-A2FF-44EEDFD1E642Q26770098-ED4783CC-7EB8-4C7C-827B-DA86F933E1C9Q26786162-8F3A271A-3480-42A7-B8D9-86DB6A0E6059Q26797261-2BF1975B-E608-428E-AE3B-FA79F5D6C8B3Q26852285-37DA672B-3A66-4545-A305-13EDA90910E7Q26853374-1E9803CC-5004-4F42-B4E9-55EBC296C54CQ26998969-4B10578E-CCC0-49F9-8929-811483053834Q27015774-C5434D4D-D46F-4EEE-9A94-7E61810F3E7EQ27320712-595E8CFB-8B64-4CA2-BD08-AF7869B105B6Q28071840-17F13B17-5557-4F85-ABF2-FFB467600550Q28071916-71ABB17E-F868-4B41-A44A-2CCB4CFD9C1DQ28076273-962E516D-D2F2-4AAE-B43B-FD97BCB2182EQ28079373-DA349967-9F6C-47DE-9DCB-DECE9E9AA78EQ28387894-73ED6E85-3FE3-4E81-A4CC-51C3DCE6EEB6Q28392956-8DB9F19F-6685-47BD-BA6C-157A50DA8B52Q30413056-01411D1F-B5F8-4D0C-9F0C-58DF825D0D6CQ30541785-2577A846-A038-4F69-95C0-A05FE31D9FC7Q30763711-8D89791C-0BB9-4782-BE96-774C25990A88Q33722392-4C4DC7C4-0985-4E6B-8B3B-01F23068152DQ33724205-83C0BFAC-6C16-464A-927B-3511E04462E9Q33728374-F66097A8-A66A-45BC-8658-7FE6A414BD43Q33783282-EC6C78A7-C87A-4A31-8D17-0308E528437EQ33811247-3352861E-C02F-419A-B307-D754C4B480C7Q33834736-6EC76D63-19B4-4065-9C8A-122B333AABF8Q33893959-1428EBBC-5532-467A-A274-EF4118934843Q34072169-38E3F2B5-1954-4E96-97E3-1AC459D0FAC4Q34150828-C5D94A2B-7665-485D-B6DA-37B199AE33FCQ34278561-F7C7DFB7-4EE3-4408-9123-BAA28DE187FDQ34306572-AF38C715-5F8F-4B0F-8FF9-BD67B1292CA8Q34363534-B86E4E91-C51C-42DA-8760-6B0CC11703D8Q34419649-878D390B-82F7-4CBE-94F2-E561CA49B96AQ34456011-D622C8AB-31C3-4600-A8CE-4F3514C14EF5Q34549985-A0D93068-84D8-48C5-817C-B43C42C8C12AQ34979725-00B894E2-3B42-4B2A-B7A2-E8EECC8C8D54Q35144219-1504BD72-8970-4C30-9980-158E1D91FDEAQ35604453-943F8373-1A14-4C42-8AB8-9E6D8E4D7761Q35658853-ADDED06A-BAB4-498B-86FA-22A4D799D591
P2860
A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.
@ast
A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.
@en
type
label
A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.
@ast
A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.
@en
prefLabel
A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.
@ast
A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.
@en
P2093
P2860
P356
P1433
P1476
A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.
@en
P2093
Daniel J Weiss
Donald P Tashkin
Michelle LeRoux-Williams
Richard Casaburi
Robin Flannery
P2860
P304
P356
10.1378/CHEST.12-2094
P407
P577
2013-06-01T00:00:00Z